Stefanich EG - Search Results

1

Utilizing PK and PD Biomarkers to Guide the First-in-Human Starting Dose Selection of MTBT1466A: A Novel Humanized Monoclonal Anti-TGFβ3 Antibody for the Treatment of Fibrotic Diseases.

Yadav R, Sukumaran S, Lutman J, Mitra MS, Halpern W, Sun T, Setiadi AF, Neighbors M, Sheng XR, Yip V, Shen BQ, Liu C, Han L, Ovacik AM, Wu Y, Glickstein S, Kunder R, Arron JR, Pan L, Kamath AV, Stefanich EG. Yadav R, et al. Among authors: stefanich eg. J Pharm Sci. 2023 Nov;112(11):2910-2920. doi: 10.1016/j.xphs.2023.07.005. Epub 2023 Jul 8. J Pharm Sci. 2023. PMID: 37429356 Free article.

2

Direct labeling of rat M3-muscarinic receptors by [3H]4DAMP.

Michel AD, Stefanich E, Whiting RL. Michel AD, et al. Eur J Pharmacol. 1989 Aug 3;166(3):459-66. doi: 10.1016/0014-2999(89)90359-2. Eur J Pharmacol. 1989. PMID: 2806372

3

Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.

Sharif NA, Wong EH, Loury DN, Stefanich E, Michel AD, Eglen RM, Whiting RL. Sharif NA, et al. Br J Pharmacol. 1991 Apr;102(4):919-25. doi: 10.1111/j.1476-5381.1991.tb12277.x. Br J Pharmacol. 1991. PMID: 1830236 Free PMC article.

4

PC12 phaeochromocytoma cells contain an atypical muscarinic receptor binding site.

Michel AD, Stefanich E, Whiting RL. Michel AD, et al. Br J Pharmacol. 1989 Jul;97(3):914-20. doi: 10.1111/j.1476-5381.1989.tb12032.x. Br J Pharmacol. 1989. PMID: 2758243 Free PMC article.

5

Cloning and expression of a 5-hydroxytryptamine7 receptor positively coupled to adenylyl cyclase.

Tsou AP, Kosaka A, Bach C, Zuppan P, Yee C, Tom L, Alvarez R, Ramsey S, Bonhaus DW, Stefanich E, et al. Tsou AP, et al. J Neurochem. 1994 Aug;63(2):456-64. doi: 10.1046/j.1471-4159.1994.63020456.x. J Neurochem. 1994. PMID: 7518496

6

Allosteric interactions among agonists and antagonists at 5-hydroxytryptamine3 receptors.

Bonhaus DW, Stefanich E, Loury DN, Hsu SA, Eglen RM, Wong EH. Bonhaus DW, et al. J Neurochem. 1995 Jul;65(1):104-10. doi: 10.1046/j.1471-4159.1995.65010104.x. J Neurochem. 1995. PMID: 7790853

7

Characterization of the interaction of zamifenacin at muscarinic receptors in vitro.

Watson N, Reddy H, Stefanich E, Eglen RM. Watson N, et al. Eur J Pharmacol. 1995 Oct 16;285(2):135-42. doi: 10.1016/0014-2999(95)00394-z. Eur J Pharmacol. 1995. PMID: 8566131

8

Labelling of 5-hydroxytryptamine3 receptors with a novel 5-HT3 receptor ligand, [3H]RS-42358-197.

Wong EH, Bonhaus DW, Wu I, Stefanich E, Eglen RM. Wong EH, et al. J Neurochem. 1993 Mar;60(3):921-30. doi: 10.1111/j.1471-4159.1993.tb03238.x. J Neurochem. 1993. PMID: 8436978

9

Pharmacokinetics/pharmacodynamics of nondepleting anti-CD4 monoclonal antibody (TRX1) in healthy human volunteers.

Ng CM, Stefanich E, Anand BS, Fielder PJ, Vaickus L. Ng CM, et al. Pharm Res. 2006 Jan;23(1):95-103. doi: 10.1007/s11095-005-8814-3. Epub 2006 Nov 30. Pharm Res. 2006. PMID: 16308668

10

Production, characterization, and pharmacokinetic properties of antibodies with N-linked mannose-5 glycans.

Yu M, Brown D, Reed C, Chung S, Lutman J, Stefanich E, Wong A, Stephan JP, Bayer R. Yu M, et al. MAbs. 2012 Jul-Aug;4(4):475-87. doi: 10.4161/mabs.20737. Epub 2012 Jul 1. MAbs. 2012. PMID: 22699308 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters